

What do companies importing Class C and D medical devices from China need to prepare to avoid delays in Vietnam? When can a product qualify for the NMPA Market Authorization Fast Track to accelerate the marketing authorization process? And why do some applications still face long processing times despite having documentation from China? In this article, Green NRJ walks you through the key eligibility conditions, how to prepare a compliant dossier from the start, and the common real-world mistakes that often slow down approvals.
Table of Contents
ToggleAccording to current regulations, Class C and D medical devices are classified as high-risk, therefore, applications for marketing authorization are always subject to strict legal and technical scrutiny.
In cases where the product already has a marketing authorization or free sale certificate issued by the NMPA, the application in Vietnam may be reviewed under a fast-track process if all conditions are met. However, the important thing is not simply having the document, but the content presented on that document.
Specifically, the documentation must clearly demonstrate that the product is permitted for circulation in the Chinese domestic market, not solely for export purposes. Furthermore, information regarding the product name, model, type, and manufacturer must be complete, clear, and directly verifiable against the technical documentation submitted in Vietnam.
When these elements are consistent and valid, the application has a basis for consideration under the fast-track process, meaning that the technical assessment step can be reduced compared to the normal procedure. Conversely, if even one point is inconsistent, the application will still be processed as a normal application and the processing time will not be shortened.
From 2024 onward, applications for marketing authorization of Class C and D medical devices must be prepared in accordance with the ASEAN Common Submission Dossier Template (CSDT). This is not only a formal requirement but also demands strict consistency between all documents in the application.
In practice, applications that are well-prepared from the start, clearly presented, and contain consistent information are usually accepted quickly and require fewer additional submissions. Conversely, even a few discrepancies can lead to multiple requests for clarification.
It’s worth noting that these errors often don’t lie in complex technical details, but stem from a lack of cross-checking before submission. Once the application is in the processing stage, each additional submission not only wastes time on corrections but also requires restarting the process.
Therefore, before submission, businesses should review the entire application by comparing every detail between the documents. Although this takes more time initially, it helps avoid prolonged “file backlogs” later on.
This is a part that many businesses often overlook, but it directly affects whether the application will be considered for fast-track processing.
A very common error is inconsistent product names. For example, the certificate issued by the NMPA states “Multi-parameter patient monitor,” but the technical documentation states “Patient monitoring system.” Although essentially the same product, the different descriptions still require clarification.
Similarly, there are cases where the model number is missing or abbreviated. For instance, the certificate states the model “ABC-1000,” while the technical documentation states “ABC1000” or simply “ABC series.” These discrepancies prevent the assessment agency from accurately verifying the product.
Another error is inconsistent manufacturer information. For example, the certificate might state the company name in English, while the Vietnamese translation in the file is not legally accurate, or lacks a detailed address. This also leads to requests for additional information.
There are many cases where the certificate does not clearly indicate that the issuing authority is NMPA, or the copy lacks a valid certification stamp. In such cases, the application will almost certainly not be considered for fast-track processing.
Furthermore, a very common error is that the document only states “for export.” For example, the document clearly states that the product is manufactured for export to foreign countries, but there is no line confirming that the product is circulated in China. In this case, the application will not qualify for the simplified procedure.
Regarding translation, many applications are hampered by inaccurate Vietnamese translations. For example, the phrase “free sale” is incorrectly translated as “allowed to be sold freely,” which does not accurately reflect the legal meaning of “legally circulated.” Or the translation is not properly certified, leading to the need for resubmission.
There are also cases of inconsistencies between supporting documents, such as catalogs, user manuals, and technical specifications describing the product that do not match in terms of configuration or function.
These errors are usually not difficult to spot, but if not carefully checked before submission, each correction will prolong the processing time by several months.
Although regulations allow for shortened processing times in some cases, in reality, it heavily depends on the quality of the application.
With a large volume of applications, many cases still require waiting 10 to 16 months to complete the procedure. This makes preparing the application correctly from the start a decisive factor, rather than relying solely on the streamlined mechanism.
To shorten the registration time for Class C/D medical devices using licenses issued by the NMPA, businesses need to pay special attention to the accuracy and consistency of their applications. Even a small discrepancy can cause the application to lose the opportunity for fast-track processing. Green NRJ supports businesses in meticulously reviewing each document, detecting errors early, and completing the application according to regulations, helping to minimize risks and accelerate the process of bringing products to market.